位置:首页 > 蛋白库 > PY2CR_PSEPU
PY2CR_PSEPU
ID   PY2CR_PSEPU             Reviewed;         341 AA.
AC   Q5FB93;
DT   04-MAR-2015, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 1.
DT   03-AUG-2022, entry version 49.
DE   RecName: Full=Delta(1)-pyrroline-2-carboxylate/Delta(1)-piperideine-2-carboxylate reductase {ECO:0000303|PubMed:15561717};
DE            Short=Pyr2C/Pip2C reductase {ECO:0000303|PubMed:15561717};
DE            EC=1.5.1.21 {ECO:0000269|PubMed:15561717};
DE   AltName: Full=N-methyl-L-amino acid dehydrogenase {ECO:0000303|PubMed:15720386};
DE            Short=NMAADH {ECO:0000303|PubMed:15720386};
DE            EC=1.4.1.17 {ECO:0000269|PubMed:15561717, ECO:0000269|PubMed:15720386};
GN   Name=dpkA {ECO:0000303|PubMed:15561717};
OS   Pseudomonas putida (Arthrobacter siderocapsulatus).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=303;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF N-TERMINUS, CLEAVAGE
RP   OF INITIATOR METHIONINE, FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE
RP   SPECIFICITY, AND SUBUNIT.
RC   STRAIN=ATCC 12633 / DSM 291 / JCM 13063 / CCUG 12690 / LMG 2257 / NBRC
RC   14164 / NCIMB 9494 / NCTC 10936 / VKM B-2187 / Stanier 90;
RX   PubMed=15720386; DOI=10.1111/j.1742-4658.2004.04541.x;
RA   Mihara H., Muramatsu H., Kakutani R., Yasuda M., Ueda M., Kurihara T.,
RA   Esaki N.;
RT   "N-methyl-L-amino acid dehydrogenase from Pseudomonas putida. A novel
RT   member of an unusual NAD(P)-dependent oxidoreductase superfamily.";
RL   FEBS J. 272:1117-1123(2005).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, ACTIVITY REGULATION, DISRUPTION PHENOTYPE, AND KINETIC
RP   MECHANISM.
RC   STRAIN=ATCC 12633 / DSM 291 / JCM 13063 / CCUG 12690 / LMG 2257 / NBRC
RC   14164 / NCIMB 9494 / NCTC 10936 / VKM B-2187 / Stanier 90;
RX   PubMed=15561717; DOI=10.1074/jbc.m411918200;
RA   Muramatsu H., Mihara H., Kakutani R., Yasuda M., Ueda M., Kurihara T.,
RA   Esaki N.;
RT   "The putative malate/lactate dehydrogenase from Pseudomonas putida is an
RT   NADPH-dependent delta1-piperideine-2-carboxylate/delta1-pyrroline-2-
RT   carboxylate reductase involved in the catabolism of D-lysine and D-
RT   proline.";
RL   J. Biol. Chem. 280:5329-5335(2005).
CC   -!- FUNCTION: Catalyzes the reduction of both Delta(1)-pyrroline-2-
CC       carboxylate (Pyr2C) and Delta(1)-piperideine-2-carboxylate (Pip2C) to
CC       L-proline and L-pipecolate, respectively, using NADPH as the electron
CC       donor. Can use NADH instead of NADPH, although with much less
CC       efficiency. Plays an essential role in the catabolism of D-proline and
CC       D-lysine, which allows P.putida to grow on each of these amino-acids as
CC       a sole carbon source; D-lysine appears to be catabolized only through
CC       the pipecolate pathway. Can also catalyze the reverse oxidation
CC       reactions, albeit at a much lower rate. To a lesser extent, is able to
CC       catalyze in vitro the NADPH-dependent formation of N-alkyl-L-amino
CC       acids from the corresponding alpha-oxo acids and alkylamines, e.g. the
CC       formation of N-methylalanine from pyruvate and N-methylamine; cannot
CC       use ammonia as substrate for these reductive amination reactions. Shows
CC       neither malate dehydrogenase nor lactate dehydrogenase activity.
CC       {ECO:0000269|PubMed:15561717}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-pipecolate + NADP(+) = Delta(1)-piperideine-2-carboxylate +
CC         H(+) + NADPH; Xref=Rhea:RHEA:12524, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:61185,
CC         ChEBI:CHEBI:77631; EC=1.5.1.21;
CC         Evidence={ECO:0000269|PubMed:15561717};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-proline + NADP(+) = 1-pyrroline-2-carboxylate + H(+) +
CC         NADPH; Xref=Rhea:RHEA:20317, ChEBI:CHEBI:15378, ChEBI:CHEBI:39785,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:60039; EC=1.5.1.21;
CC         Evidence={ECO:0000269|PubMed:15561717};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + N-methyl-L-alanine + NADP(+) = H(+) + methylamine +
CC         NADPH + pyruvate; Xref=Rhea:RHEA:21768, ChEBI:CHEBI:15361,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58175, ChEBI:CHEBI:58349, ChEBI:CHEBI:59338; EC=1.4.1.17;
CC         Evidence={ECO:0000269|PubMed:15561717, ECO:0000269|PubMed:15720386};
CC   -!- ACTIVITY REGULATION: Is inhibited by the substrate analog pyrrole-2-
CC       carboxylate, but not by N-formylphenylalanine.
CC       {ECO:0000269|PubMed:15561717}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=43 uM for Delta(1)-pyrroline-2-carboxylate
CC         {ECO:0000269|PubMed:15561717};
CC         KM=15 uM for Delta(1)-piperideine-2-carboxylate
CC         {ECO:0000269|PubMed:15561717};
CC         KM=144 mM for L-proline {ECO:0000269|PubMed:15561717};
CC         KM=32.4 mM for L-pipecolate {ECO:0000269|PubMed:15561717};
CC         KM=34 uM for NADPH (with Pyr2C as cosubstrate)
CC         {ECO:0000269|PubMed:15561717};
CC         KM=140 uM for NADPH (with Pip2C as cosubstrate)
CC         {ECO:0000269|PubMed:15561717};
CC         KM=211 uM for NADP(+) (with L-proline as cosubstrate)
CC         {ECO:0000269|PubMed:15561717};
CC         KM=112 uM for NADP(+) (with L-pipecolate as cosubstrate)
CC         {ECO:0000269|PubMed:15561717};
CC         Vmax=168 umol/min/mg enzyme for Pyr2C reduction
CC         {ECO:0000269|PubMed:15561717};
CC         Vmax=220 umol/min/mg enzyme for Pip2C reduction
CC         {ECO:0000269|PubMed:15561717};
CC         Vmax=0.271 umol/min/mg enzyme for L-proline oxidation
CC         {ECO:0000269|PubMed:15561717};
CC         Vmax=0.118 umol/min/mg enzyme for L-pipecolate oxidation
CC         {ECO:0000269|PubMed:15561717};
CC       pH dependence:
CC         Optimum pH is 7.0 for Pyr2C reduction, 8.0 for Pip2C reduction, and
CC         10.0 for L-proline and L-pipecolate oxidation.
CC         {ECO:0000269|PubMed:15561717};
CC       Temperature dependence:
CC         Optimum temperature is 35 degrees Celsius. Is inactivated at a rate
CC         of about a 30% decrease in 30 minutes at 35 degrees Celsius. The
CC         enzyme keeps its full activity, however, at 30 degrees Celsius for at
CC         least 30 minutes. {ECO:0000269|PubMed:15561717};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15720386}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene loss their ability to
CC       grow on D-lysine and also on D-proline as a sole carbon source.
CC       Moreover, the mutant strain grows only slowly in the medium containing
CC       L-lysine as a sole carbon source in contrast to the wild-type strain.
CC       No difference is evident between the two strains in other media
CC       containing as a sole carbon source L-pipecolate, L-proline, and the
CC       following D-amino acids: D-alanine, D-valine, D-leucine, D-isoleucine,
CC       D-serine, D-threonine, D-aspartate, D-glutamate, D-glutamine, D-
CC       arginine, and D-phenylalanine. {ECO:0000269|PubMed:15561717}.
CC   -!- MISCELLANEOUS: The enzyme reaction proceeds through an ordered Bi-Bi
CC       mechanism. {ECO:0000269|PubMed:15561717}.
CC   -!- SIMILARITY: Belongs to the LDH2/MDH2 oxidoreductase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB190215; BAD89743.1; -; Genomic_DNA.
DR   AlphaFoldDB; Q5FB93; -.
DR   SMR; Q5FB93; -.
DR   KEGG; ag:BAD89743; -.
DR   BRENDA; 1.5.1.21; 5092.
DR   GO; GO:0047125; F:delta1-piperideine-2-carboxylate reductase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050132; F:N-methylalanine dehydrogenase activity; IEA:UniProtKB-EC.
DR   Gene3D; 1.10.1530.10; -; 1.
DR   Gene3D; 3.30.1370.60; -; 1.
DR   InterPro; IPR043144; Mal/L-sulf/L-lact_DH-like_ah.
DR   InterPro; IPR043143; Mal/L-sulf/L-lact_DH-like_NADP.
DR   InterPro; IPR036111; Mal/L-sulfo/L-lacto_DH-like_sf.
DR   InterPro; IPR003767; Malate/L-lactate_DH-like.
DR   PANTHER; PTHR11091; PTHR11091; 1.
DR   Pfam; PF02615; Ldh_2; 1.
DR   SUPFAM; SSF89733; SSF89733; 1.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; NADP; Oxidoreductase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:15720386"
FT   CHAIN           2..341
FT                   /note="Delta(1)-pyrroline-2-carboxylate/Delta(1)-
FT                   piperideine-2-carboxylate reductase"
FT                   /id="PRO_0000432290"
FT   ACT_SITE        52
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:Q4U331"
FT   ACT_SITE        53
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:Q4U331"
FT   ACT_SITE        193
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:Q4U331"
FT   BINDING         57
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q4U331"
FT   BINDING         125..129
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000250|UniProtKB:Q4U331"
FT   BINDING         165
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q4U331"
FT   BINDING         183..185
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000250|UniProtKB:Q4U331"
FT   BINDING         191..192
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q4U331"
FT   BINDING         235..236
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /evidence="ECO:0000250|UniProtKB:Q4U331"
FT   BINDING         308..314
FT                   /ligand="NADP(+)"
FT                   /ligand_id="ChEBI:CHEBI:58349"
FT                   /ligand_note="ligand shared between dimeric partners"
FT                   /note="in other chain"
FT                   /evidence="ECO:0000250|UniProtKB:Q4U331"
SQ   SEQUENCE   341 AA;  35973 MW;  1DC92DE2372822C2 CRC64;
     MSAPSTSTVV RVPFTELQSL LQAIFQRHGC SEAVARVLAH NCASAQRDGA HSHGVFRMPG
     YVSTLASGWV DGQATPQVSD VAAGYVRVDA AGGFAQPALA AARELLVAKA RSAGIAVLAI
     HNSHHFAALW PDVEPFAEEG LVALSVVNSM TCVVPHGARK PLFGTNPIAF AAPCAEHDPI
     VFDMATSAMA HGDVQIAARA GQQLPEGMGV DADGQPTTDP KAILEGGALL PFGGHKGSAL
     SMMVELLAAA LTGGHFSWEF DWSGHPGAKT PWTGQLIIVI NPGKAEGERF AQRSRELVEH
     MQAVGLTRMP GERRYREREV AEEEGVAVTE QELQGLKELL G
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024